Introduction
Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) belonging to the class of oxicam. 1 Crystalline piroxicam is known 20 to show polymorphism, which has been studied quite extensively since its discovery. The compound is established to crystallize in several anhydrous forms, 2-5 and one monohydrate form. 6 For the anhydrous compound, there are currently eight entries in the Cambridge Structural Database (CSD; Nov. 2013 release plus 25 updates), which fall into four structural groups (Table 1) . As is often the case for well-studied compounds, the nomenclature of the polymorphs in the primary literature is inconsistent. The situation up to 2004 was summarised in a helpful article by Sheth et al. 4 Form I (also called the β form) was the first structure to be 30 described (CSD: BIYSEH), 2 and it crystallizes commonly by slow cooling from various solvents. Form III was observed by Vrečer et al. in 2003, 7 and has been obtained by rapid pouring of hot saturated solutions onto dry ice 7 or by spray drying. 5 The crystal structure of form III was determined from powder X-ray 35 diffraction (PXRD) data in 2012 (BIYSEH07). 5 The subject of this paper is the polymorph originally labelled as the α form, and later (ambiguously) re-labelled as form II. 8 An orthorhombic crystal structure was first reported from singlecrystal data in 1988 by Reck et al. (BIYSEH02) . 3 In that paper, 40 the authors noted that Weissenberg photographs contained diffuse strips and a few weak additional reflections, which led them to propose an order-disorder (OD) model, 9 with the orthorhombic form being one maximum-degree-of-order (MDO) structure. On the basis of the OD model, a monoclinic structure corresponding 45 to a second MDO structure was deduced. 10 The orthorhombic and monoclinic structures were labelled α 1 and α 2 , respectively, and they are polytypes. 11 Reck et al. initially showed the existence of α 1 and α 2 by comparing to measured PXRD patterns, and they noted that the α 1 and α 2 structures frequently appear in varying 50 ratios in bulk samples. A single-crystal structure for α 2 was later determined by Vrečer et al. (BIYSEH06), 7 where the authors refer to it as form II.
Scheme 1 Molecular structure of piroxicam 55 Although the polytypic relationship and probable disordered nature of α 1 and α 2 was described by Reck et al. in 1990, 10 the identity of the polymorphs does not seem to be clear in the subsequent literature. This is possibly because of the close structural relationship between the polytypes or perhaps because 60 of the introduction of the ambiguous form II label by Vrečer et al. 7 The summary article by Sheth et al. is unclear on this point: it states that "…form II has also been named α, α 1 , α 2 …", 4 which indicates that all three α labels refer to the same "form II". In this article, we aim to clarify the existence and identity of the on account of the polytypic relationship between forms I and II. 12, 13 A similar situation has also been shown for felodipine, where crystals reported to be form II comprise domains of two polytypes. 14 
Materials and Methods
Piroxicam (USP32) was purchased from Chr. Olesen Pharmaceuticals A/S (Gentofte, Denmark) and was found to be Form I by PXRD. All solvents used were of HPLC grade with 15 purity ≥99.8 %.
Crystallization experiments
Crystallization experiments were set up at concentrations 2.0, 5.0, 10.0 and 15.0 mg/mL in various solvents as listed in Table 2 . The samples at 2.0 mg/mL were sonicated for 10 mins in order to 20 obtain a clear solution. At 5.0 mg/mL in methanol, ethanol, acetonitrile and n-propanol, a suspension was formed upon sonication, which was further heated to 50°C to obtain a clear solution. At 10.0 and 15.0 mg/mL, all samples except for acetone, dichloromethane, dimethylsulfoxide and dimethylacetamide 25 formed a suspension and were heated to obtain a clear solution. All hot solutions were cooled slowly to room temperature (preventing rapid crashing) and left to evaporate at either 25 or 4°C.
X-Ray Diffraction
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Single-crystal X-ray diffraction data were collected on a Bruker D8-QUEST instrument, equipped with a PHOTON-100 detector and an Incoatec IµS microsource (CuKα radiation; λ = 1.5418 Å) at 298 K. Data collection and reconstruction of precession images were carried out using the APEX2 package. 16 Powder X-ray 35 diffraction data were collected on a Panalytical X'Pert Pro instrument, equipped with a PIXcel detector using nonmonochromated CuKα radiation (λ = 1.5418 Å). The sample was placed in a zero-background Si holder and measured in reflection geometry with sample spinning. Samples were ground thoroughly 40 before mounting in an effort to minimise preferred orientation. The PXRD patterns were fitted by Pawley refinement using TOPAS Academic, 17 starting from the unit-cell parameters of BIYSEH02 (α 1 ) and BIYSEH05 (α 2 ).
Computational Methods
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Energy minimisation of the crystal structures was carried out using the CASTEP module 18 in Materials Studio. 19 The starting structures were BIYSEH05 (α 2 ) and a transformed version of BIYSEH02 (α 1 ) as described in the Results and Discussion section. The PBE functional was applied 20 with a plane-wave cut-50 off energy of 520 eV and a dispersion correction according to Grimme. 21 All other parameters were set to the "fine" defaults within Materials Studio; full details are included in the ESI † . All atomic coordinates and unit-cell parameters were optimized.
Results and Discussion
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Crystallization studies
We have crystallized piroxicam under various conditions and solvents, as summarized in Table 2 , with an emphasis on targeting the α 1 and α 2 forms. Numerous other authors have reported piroxicam crystallization results, so the following 60 discussion compares to the published results where relevant.
Michalić et al. were first to describe the crystallization behaviour in ethanol in 1982. 1 They stated that fast cooling of saturated ethanolic solutions leads to the "needle form" whereas slow cooling produces the "cubic form". The "cubic form" is In 1991, Janik et al. studied the influence of various solvents on the crystallization behaviour, and reported that the "α structure" crystallized from ethanol, isopropanol, THF, acetonitrile and chloroform. 23 We find some conflicting results: 10 we observe that form I crystallizes as large rods from acetonitrile or chloroform under slow evaporation at 25°C. However, the conclusions of Janik et al. were made solely on the basis of IR spectra, without measurement of PXRD patterns, so the effectiveness of their polymorph identification may be in doubt. 15 Also in 1991, Vrečer et al. produced α 1 by crash cooling of methanol, ethanol, acetone, n-propanol or chloroform solutions. 8 The identity of α 1 is clear from the published DSC traces (compared to our DSC traces reported herein), but accompanying PXRD data were not reported and the authors did not make any 20 distinction between α 1 and α 2 . Indeed, they refer to "form II" in their 1991 paper for obtained α 1 samples, but in 2003 refer again to "form II" for samples that are clearly α 2 . We observe that α 1 is obtained exclusively and reproducibly by slow evaporation of piroxicam solutions in ethanol, methanol, acetone or isopropyl 25 acetate at reduced temperature (around 4°C). As seen in SEM images (Fig. 2) , α 1 crystallizes as fine needles. The PXRD patterns of the bulk crystallized materials ( Fig. 3 ) match well with the pattern simulated from BIYSEH02. In summary: we find that α 1 can be crystallized reproducibly from ethanol, methanol, acetone or isopropylacetate at 4°C, while α 2 crystallizes from ethanol at 25°C, but undergoes solvent- To enable a direct comparison between the crystal structures of α 1 and α 2 , we transform the published structure of BIYSEH02 45 (α 1 ) using the matrix [0 1 0 / -1 0 0 / 0 0 1] to give unit-cell parameters a = 17.4, b = 11.8, c = 7.0 Å in the non-standard space group setting Pbc2 1 . H atoms are not included in BIYSEH02, but can be unambiguously added in geometrical positions. This transformed structure of BIYSEH02 is compared below to the 50 CSD entry BIYSEH05 (α 2 ). The two structures contain identical layers in the bc planes, but the a axis (the long axis) is aligned differently. The orthorhombic unit cell of α 1 can be transformed to the monoclinic unit cell of α 2 by application of the transformation matrix [1 0 ⅓ / 0 1 0 / 0 0 55 1], which corresponds to shearing of the unit cell parallel to the c axis, i.e. a(α 2 ) = a(α 1 ) + ⅓c(α 1 ). In projection along the c axis, the structures appear identical (Fig. 4) . The difference is seen in projection along the b axis (Fig. 4) . The layers in α 1 are related by 2 1 screw axes parallel to c, and by b-and c-glides 60 perpendicular to the a and b axes, respectively The structure is non-centrosymmetric and polar, with all N-CH 3 vectors pointing in the same direction along the c axis. In the α 2 structure, inversion centres exist between the layers. The two alternative orientations for a given layer are related to each other by a mirror 65 operation perpendicular to the c axis ( Fig. 5 ).
There are two different interlayer regions: one where the pyridyl rings meet (at the upper and lower edges of the unit cell drawn in Fig. 4) , and one where the benzothiazine ends of the molecules meet (at the middle of the unit cell in Fig. 4 ). In both regions, the local intermolecular relationships are mirrored, but 5 the contacts remain similar. The principal interactions are C-H···O from the pyridyl and benzothiazine rings to the O atoms of the S=O, C=O and C-OH groups. The intermolecular interactions and their energies are discussed in more detail subsequently. Relationship between the diffraction patterns 20 One of our principal interests with the α 1 and α 2 piroxicam structures is their polytypic relationship and the potential for stacking faults and/or intergrowth polymorphism, similar to aspirin. 12, 13 By considering the relationship between the singlecrystal diffraction patterns of the two forms, we consider here 25 how such phenomena would be observed. With the consistent layers in both structures lying in the bc planes, α 1 and α 2 have their a* and b* axes aligned, but not their c* axes. The idealized geometry in the plane containing a* and c* is shown in Fig. 6 . α 1 has an orthorhombic lattice with c* perpendicular to a*, and 30 parallel to the c axis in real space (horizontal in Fig. 6 ). In α 2 , c* makes an angle of ~7° to this direction. The geometry is such that the diffraction spots along a* for α 2 are offset by one third of the lattice spacing for α 1 . This offset could occur in either direction, giving three sets of evenly-spaced diffraction spots along a* (Fig.   35   6 ). Since the (idealized) offset between the spots is ⅓a*, the lattices come back into coincidence in every third row along c* (i.e. l = 0, 3, 6, etc.). This is also expressed by the transformation matrix relating the two unit cells: [1 0 ⅓ / 0 1 0 / 0 0 1]. The observation of three sets of discrete Bragg spots, as indicated in 40 Fig. 6 , would refer to a situation where the domain sizes of the three cases (α 1 + α 2 in two different orientations related by 180° rotation around the c axis) were suitably large. Smaller domain sizes, corresponding to more frequent turnover between domains, would generate diffuse streaks along a* for l ≠ 0, 3, 6, etc. 45 Fig. 6 Schematic illustration of the idealized geometry for the diffraction patterns of α1 and α2 in the a*c* planes. Blue spots correspond to orthorhombic α1. Red and green spots correspond to two orientations of monoclinic α2, related to each other by 2-fold rotation around the real c 50 axis (horizontal). The black spots are coincident in all three lattices.
Single-crystal X-ray diffraction
Crystals of α 1 obtained from ethanol at 4°C were studied by single-crystal X-ray diffraction. A representative reconstructed precession image for the h1l plane is shown in Fig. 7 . In the 55 image shown, faint diffuse streaks are visible along a*, which give some indication of layer stacking disorder, but we have not observed any crystals with additional Bragg peaks that might indicate significant α 2 domains. Since the structure is noncentrosymmetric, the presence of one stacking fault 60 corresponding to the inversion-related interlayer arrangement in α 2 would manifest itself as inversion twinning. We have found some crystals where the Flack parameter refines to zero (indicating no inversion twinning) and others where it refines to a non-zero value (with suitably small uncertainty) due to inversion twinning. Thus, twinning of the α 1 structure by incorporation of the α 2 interlayer arrangement is found to occur, but to date we 5 have not observed any clear indications of sizeable α 2 domains within α 1 single crystals. A representative structure from our α 1 crystal has been deposited at the Cambridge Crystallographic Data Centre (CCDC 1050926). Numerous crystals of α 2 were studied, and these were frequently found to be twinned. Using the unit cell established for α 2 in space group P2 1 /c (a ≈ 17.6, b ≈ 11.9, c ≈ 7.0 Å, β ≈ 97°), 15 the relationship between the twin domains was established to be a 180° rotation around the c axis, as indicated in Fig. 6 . A typical reconstructed precession image for the h1l plane is shown in Fig.  8 . The Bragg reflections of the two twin components are clearly separated, and diffuse streaks indicate less ordered regions. The 20 coincidence of the two lattices for l = 3 is apparent. The twin operation corresponds to introduction of the α 1 interlayer arrangement, but again we have not observed any clear indications of Bragg reflections corresponding to sizeable α 1 domains within α 2 single crystals. A representative α 2 structure 25 has been deposited at the Cambridge Crystallographic Data Centre (CCDC 1050927). Finally, it is interesting to note that twinned α 2 crystals indexed in a standard way commonly indicate a ≈ 52.3 Å (≈ 3 × 17.6 Å). The reason for this is clear from Figs. 6 and 8. A similar long axis was reported by Reck et al. 3 in their first determination 35 of the α 1 structure, i.e. the orthorhombic form. This could indicate that their α 1 crystals contained sizeable domains of the α 2 structure (i.e. their diffraction pattern resembled the situation in Fig. 6 ). This would amount to intergrowth polymorphism, similar to the situation reported for aspirin 12, 13 and felodipine 40 form II. 14 We have not reproduced any such result to date, but it is clear from the polytypic relationship that there is potential for such a situation to exist.
Thermal analysis
Thermal analysis of bulk α 1 and α 2 was carried out by differential 45 scanning calorimetry (DSC), with form I also measured for comparison ( Fig. 9) . Form I shows a single sharp melting endotherm with onset 201.2°C. α 2 also shows a single sharp melting endotherm with onset 198.8°C, which matches well with the α 2 melting point reported by . 1 50 For α 1 , a first endotherm is seen at 194.8°C, corresponding to melting, followed by an exotherm that corresponds to crystallization of form I then a subsequent melting endotherm for form I. 
Intermolecular interaction energies
To obtain an indication of the relative stabilities of α 1 and α 2 , the structures of BIYSEH02 (α 1 ) and BIYSEH05 (α 2 ) were energyminimized using dispersion-corrected density functional theory 60 calculations (DFT-D). Details and minimized structures are provided in the ESI. † The resulting energies (at 0 K) suggest that α 2 is moderately more stable than α 1 , which is nominally consistent with the observed melting points. Pairwise intermolecular interaction energies were then calculated from the 65 minimized structures using the PIXEL method (Table 3 ). 24 The total potential energy for a molecule in each structure is indistinguishable within the expected precision of these calculations. However, the distribution of the interactions is different. The results are visualised in Fig. 10 using energy-vector 70 diagrams of the type developed by Shishkin and co-workers, 25 generated using the processPIXEL program. 26 Table 3 shows sums of the principal stabilising interactions partitioned into intra-and interlayer regions. The most striking result is that the pyridyl interlayer region in the α 2 structure is calculated to be more stabilising than any of the other interlayer regions. This is mainly due to a particularly stabilising pairwise interaction between inversion-related molecules, with a substantial coulombic component originating from C-H···O interactions 5 involving both SO 2 groups (Fig. 11) . The corresponding noncentrosymmetric interaction in the α 1 structure involves only one such contact and is substantially less stabilising. If the twinning in both structures were to be controlled by the intermolecular interaction energies, Table 3 implies the following observations: 10 (i) inversion twinning in the non-centrosymmetric α 1 structure is most likely to occur at the pyridyl interlayer region; (ii) twinning in the α 2 structure is most likely to occur at the benzothiazine interlayer region. Fig. 10 Energy-vector diagrams representing the results of PIXEL calculations for α1 and α2. The most stabilising interaction in each structure is represented by a continuous line joining the centroids of the molecules. Other interactions are represented by discontinuous lines, with a larger gap indicating a less stabilising interaction. 25,26 25 Fig . 11 The most stabilising pairwise intermolecular interaction in the α2 structure: centrosymmetric, with C-H···O interactions (light blue lines) between the pyridyl rings and SO2 groups.
Conclusions
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With this clarification of the structures of piroxicam forms α 1 and α 2 , and a specific report of crystallization conditions for both, piroxicam has four well-established polymorphs. We have chosen to retain the α 1 /α 2 notation of Reck et al. in order to maintain consistency with the original work. Where the "form II" label 35 introduced by Vrečer et al. is seen in the literature, it should be considered carefully whether the information in the paper is sufficient to distinguish α 1 from α 2 . We have obtained singlecrystal data that show that orthorhombic α 1 can exist with only minimal twinning/disorder, but single crystals that we have 40 obtained for monoclinic α 2 have frequently been twinned. So far, we have not obtained any single crystals that show clear domains of both the α 1 and α 2 polymorphs simultaneously, as would be the case for intergrowth polymorphism. This article certainly does not represent the end of the story for 45 piroxicam polymorphism. We are currently aware of two additional crystal structures, one of which we have obtained during our solution crystallization experiments, and one of which has its unit-cell parameters and simulated PXRD pattern reported. 27 The latter is a high Z′ form. There has also been a 50 recent report of a further new form obtained from chloroform solution by electrospray methods, 28 and we have produced similar PXRD patterns in the course of our work. Thus, at least two more anhydrous piroxicam crystal structures are already known, and there appears to exist one other solid form whose structure is yet 55 to be established. This will bring the known total (so far) up to seven polymorphs, making piroxicam one of the more prolific polymorphic pharmaceutical compounds.
